General Information of the Compound
Compound ID |
CP0016203
|
||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Compound Name |
Bis-(5-hydroxy-1H-indol-2-yl)-methanone
Show/Hide
|
||||||||||||||||||
Synonyms |
896138-40-2
AKOS028113701
BDBM50187351
Bis(5-hydroxy-1H-indol-2-yl)methanone
Bis-(5-hydroxy-1H-indol-2-yl)-methanone
Bis-(5-hydroxy-1H-indol-2-yl)methanone
CCG-206752
CHEMBL377193
CTK8F1061
DTXSID40469293
Flt-3 Inhibitor II
Flt-3 inhibitor II
GTPL5971
HMS3229E09
IN1480
RT-012728
SCHEMBL2230377
Show/Hide
|
||||||||||||||||||
Structure |
|
||||||||||||||||||
Formula |
C17H12N2O3
|
||||||||||||||||||
Molecular Weight |
292.294
|
||||||||||||||||||
Canonical SMILES |
Oc1ccc2[nH]c(cc2c1)C(=O)c1cc2cc(O)ccc2[nH]1
Show/Hide
|
||||||||||||||||||
InChI |
InChI=1S/C17H12N2O3/c20-11-1-3-13-9(5-11)7-15(18-13)17(22)16-8-10-6-12(21)2-4-14(10)19-16/h1-8,18-21H
Show/Hide
|
||||||||||||||||||
InChIKey |
NIMIWWQLOGNYHD-UHFFFAOYSA-N
|
||||||||||||||||||
Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
PubChem ID | |||||||||||||||||||
ChEMBL ID |
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT00888, Mast/stem cell growth factor receptor Kit
Protein ID: PT01204, Receptor-type tyrosine-protein kinase FLT3
Clinical Information about the Compound
Drug 1 ( Bis-(5-hydroxy-1H-indol-2-yl)-methanone )
Drug Name | Bis-(5-hydroxy-1H-indol-2-yl)-methanone | ||
---|---|---|---|
Target(s) |